The CJC-1295 and Ipamorelin pairing is studied for how two complementary mechanisms influence growth-hormone-axis signaling together.
In-vitro research
Cell-based assays characterize receptor binding and signaling for each peptide separately — CJC-1295 at the GHRH receptor, Ipamorelin at the secretagogue receptor — at defined in-vitro concentrations.
Animal-model research
Animal models examine how the two together influence pulsatile growth-factor signaling relative to either alone, the core reason the blend is of research interest. See their research overview and how the two compare.
Product page: CJC-1295 + Ipamorelin research vials.
Research Use Only. Supplied strictly for laboratory research and development — not for human or veterinary use, consumption, or any therapeutic or diagnostic purpose. This article is research education, not usage guidance.